Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arild Holth

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 27, 2026
FAT1 is differentially expressed in cancers affecting the serosal cavitiesBen Davidson, Arild Holth
Virchows Archiv : an International Journal of Pathology|May 31, 2020
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Arild Holth, Hiep Phuc Dong
Pathology, Research and Practice|December 22, 2024
Expression of PRAME in high-grade serous carcinoma is associated with higher residual disease volume and Occludin expressionKatharina Bischof, Arild Holth, Assia Bassarova, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 7, 2024
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine LeiomyosarcomaBen Davidson, Tone Skeie-Jensen, Arild Holth, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2023
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinomaBen Davidson, Delfim Doutel, Arild Holth, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 24, 2025
Grainyhead-Like 2 Expression Is Associated with Disease Progression, Chemoresistance and Poor Survival in Tubo-Ovarian High-Grade Serous CarcinomaBen Davidson, Silke Hauladen, Arild Holth, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 7, 2020
The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinomaBen Davidson, Annika Jøntvedt Bock, Arild Holth, et al.
Clinical & Experimental Metastasis|December 23, 2023
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistanceMargarida Varela Dos Santos, Arild Holth, Katharina Bischof, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 3, 2020
Expression of palladin is associated with disease progression in metastatic high-grade serous carcinomaBen Davidson, Annika Jøntvedt Bock, Arild Holth, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 30, 2024
Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal MesotheliomaBen Davidson, Arild Holth, Charlotte Hummel, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 27, 2026
FAT1 is differentially expressed in cancers affecting the serosal cavitiesBen Davidson, Arild Holth
Virchows Archiv : an International Journal of Pathology|May 31, 2020
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Arild Holth, Hiep Phuc Dong
Pathology, Research and Practice|December 22, 2024
Expression of PRAME in high-grade serous carcinoma is associated with higher residual disease volume and Occludin expressionKatharina Bischof, Arild Holth, Assia Bassarova, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 7, 2024
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine LeiomyosarcomaBen Davidson, Tone Skeie-Jensen, Arild Holth, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2023
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinomaBen Davidson, Delfim Doutel, Arild Holth, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 24, 2025
Grainyhead-Like 2 Expression Is Associated with Disease Progression, Chemoresistance and Poor Survival in Tubo-Ovarian High-Grade Serous CarcinomaBen Davidson, Silke Hauladen, Arild Holth, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 7, 2020
The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinomaBen Davidson, Annika Jøntvedt Bock, Arild Holth, et al.
Clinical & Experimental Metastasis|December 23, 2023
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistanceMargarida Varela Dos Santos, Arild Holth, Katharina Bischof, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 3, 2020
Expression of palladin is associated with disease progression in metastatic high-grade serous carcinomaBen Davidson, Annika Jøntvedt Bock, Arild Holth, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 30, 2024
Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal MesotheliomaBen Davidson, Arild Holth, Charlotte Hummel, et al.
Pageof 6